Bringing Transparency to the Treatment of Transgender Persons
Issues Law Med
.
2019 Fall;34(2):147-152.
Author
Quentin L Van Meter
1
Affiliation
1
Van Meter Pediatric Endocrinology, P.D. Disclosures: (1) Dr. Van Meter is a member of the speaker's bureau for the following companies: Endo, Abbvie, Novo Nordisk, Pfizer; and (2) Dr. Van Meter is involved in clinical trials with Versartis.
PMID:
33950603
No abstract available